Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
Sabeel AI, Kurkus J, Lindholm T. Intensive Hemodialysis and Hemoperfusion Treatment of Amanita Mushroom Poisoning. Mycopathologia 1995;131:107-14.
Vita PM, Restelli A, Caspani P, et al. [Chronic use of glucomannan in the dietary treatment of severe obesity]. Minerva Med 1992;83:135-9.
Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology 1999;13:1003-8.
Baur A, Harrer T, Peukert M, et al. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication. Klin Wochenschr 1991;69:722-4.
Anon. Alpha-lipoic acid. Altern Med Rev 1998;3:308-10.
Berkson BM. Thioctic acid in treatment of hepatotoxic mushroom (Phalloides) poisoning (letter). N Engl J Med 1979;300:371.
Roldan EJ, Perez Lloret A. Thioctic acid in Amanita poisoning (letter). Crit Care Med 1986;14:753-4.
Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997;29:315-31.
Matalon R, Stumpf DA, Michals K, et al. Lipoamide dehydrogenase deficiency with primary lactic acidosis: favorable response to treatment with oral lipoic acid. J Pediatr 1984;104:65-9.
Yoshida I, Sweetman L, Kulovich S, et al. Effect of lipoic acid in patient with defective activity of pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and branched-chain keto acid dehydrogenase. Pediatr Res 1990;27:75-9.
Dana Consortium on the therapy of HIV dementia and related cognitive disorders. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 1998;50:645-51.
Maesaka H, Komiya K, Misugi K, Tada K. Hyperalaninemia hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver; treatment with thiamine and lipoic acid. Eur J Pediatr 1976;122:159-68.
Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997;22:359-78.
Merin JP, Matsuyama M, Kira T, et al. Alpha-lipoic acid blocks HIV-1 LTR-dependent expression of hygromycin resistance in THP-1 stable transformants. FEBS Lett 1996;394:9-13.
Suzuki YJ, Aggarwal BB, Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun 1992;189:1709-15.
Janssen K, Mensink RP, Cox FJ, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;67:255-62.
Ziegler D, Hanefeld M, Ruhnau K, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month, multicenter, randomized, controlled trial (ALADIN III Study). Diabetes Care 1999;22:1296-301.
Reljanovic M, Reichel G, Rett K, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A 2-year, multicenter, randomized, double-blind, placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy [abstract]. Free Radic Res 1999;31:171-7.
Ziegler D, Schatz H, Conrad F, et al. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. Diabetes Care 1997;20:369-73.
Streeper RS, Henriksen EJ, Jacob S, et al. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol 1997;273:E185-91.
Konrad T, Vicini P, Kusterer K, et al. Alpha-lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with Type 2 diabetes. Diabetes Care 1999;22:280-7.
Packer L. Antioxidant properties of lipoic acid and its therapeutic effects in prevention of diabetes complications and cataracts. Ann N Y Acad Sci 1994;738:257-64.
Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the antioxidant alpha-lipoic acid: A 3-week, multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995;38:1425-33.
Ruhnau KJ, Meissner HP, Finn JR, et al. Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet Med 1999;16:1040-3.
Sachse G, Willms B. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. Hormone Metab Res Suppl 1980;9:105-7.
Gleiter CH, Schreeb KH, Freudenthaler S, et al. Lack of interaction between thioctic acid, glibenclamide and acarbose. Br J Clin Pharmacol 1999;48:819-25.
Packer L, Witt EH, Tritschler HJ. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 1995;19:227-50.
Teichert J, Kern J, Tritschler HJ. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther 1998;36:625-8.
Nagamatsu M, Nickander KK, Schmelzer JD, et al. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabet Care 1995;18:1160-7.
Jacob S, Henriksen EJ, Tritschler HJ, et al. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Exp Clin Endocrinol Diabet 1996;104:284-8.
Jacob S, Henriksen EJ, Schiemann AL, et al. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 1995;45:872-4.
Jacob S, Ruus P, Hermann R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled, pilot trial. Free Rad Biol Med 1999;27:309-14.
Haramaki N, Assadnazari H, Zimmer G, et al. The influence of vitamin E and dihydrolipoic acid on cardiac energy and glutathione status under hypoxia-reoxygenation. Biochem Mol Biol Int 1995;37:591-7.
Kishi Y, Schmelzer JD, Yao JK, et al. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes 1999;48:2045-51.
Bustamante J, Lodge JK, Marcocci L, et al. Alpha-lipoic acid in liver metabolism and disease. Free Rad Biol Med 1998;24:1023-39.
Marshall AW, Graul RS, Morgan MY, Sherlock S. Treatment of alcohol-related liver disease with thioctic acid: a six-month, randomized, double-blind trial. Gut 1982;23:1088-93.
Conlon BJ, Aran JM, Erre JP, Smith DW. Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res 1999;128:40-4.
Vilas GL, Aldonatti C, San Martin de Viale LC, Rios de Molina MC. Effect of Alpha-lipoic acid amide on hexachlorobenzene porphyria. Biochem Mol Biol Int 1999;47:815-23.
Gurer H, Ozgunes H, Oztezcan S, Ercal N. Antioxidant role of alpha-lipoic acid in lead toxicity. Free Rad Biol Med 1999;27:75-81.
Altenkirch H, Stoltenburg-Didinger G, Wagner HM, et al. Effects of lipoic acid in hexacarbon-induced neuropathy. Neurotoxicol Teratol 1990;12:619-22.
Fuchs J, Schofer H, Milbradt R, et al. Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung 1993;43:1359-62.
Segermann J, Hotze A, Ulrich H, Rao GS. Effect of alpha-lipoic acid on the peripheral conversion of thyroxine to triiodothyronine and on serum lipid-, protein- and glucose levels. Arzneimittelforschung 1991;41:1294-8.
Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid. Diabetes Care 2003;26:770-6.
Beitner H. Randomized, placebo controlled, double-blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoaging of facial skin. Br J Dermatol 2003;149:841-9.
Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis. Diabet Med 2004;21:114-21.
Block G, Jensen C, Dietrich M, et al. Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation. J Am Coll Nutr 2004;23:141-7.
Prasad KN. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 2004;134:3182S-3S.
Conklin KA. Cancer chemotherapy and antioxidants. J Nutr 2004;134:3201S-3204S.
Vincent HK, Bourguignon CM, Vincent KR, Taylor AG. Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study. J Alt Complement Med 2007;13:577-84.
Furukawa N, Miyamura N, Nishida K, et al. Possible relevance of alpha lipoic acid contained in a health supplement in a case of insulin autoimmune syndrome. Diabetes Res Clin Pract 2007;75:366-7.
Galasko D. R., Peskind E., Clark C. M., Quinn J. F., Ringman J. M., Jicha G. A., Cotman C., Cottrell B., Montine T. J., Thomas R. G., Aisen P. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol 2012;69(7):836-841.
Sun Y. D., Dong Y. D., Fan R., Zhai L. L., Bai Y. L., Jia L. H. Effect of (R)-a-lipoic acid supplementation on serum lipids and antioxidative ability in patients with age-related macular degeneration. Ann Nutr Metab 2012;60(4):293-297.
Dell'Anna M. L., Mastrofrancesco A., Sala R., Venturini M., Ottaviani M., Vidolin A. P., Leone G., Calzavara P. G., Westerhof W., Picardo, M. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 2007;32(6):631-636.
Witman M. A., McDaniel J., Fjeldstad A. S., Ives S. J., Zhao J., Nativi J. N., Stehlik J., Wray D. W., Richardson R. S. A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure. Am J Physiol Heart Circ Physiol 2012;303(10):H1237-H1244.
Han T., Bai J., Liu W., Hu Y. A systematic review and meta-analysis of a-lipoic acid in the treatment of diabetic peripheral neuropathy. Eur J Endocrinol 2012;167(4):465-471.
Lopez-D'alessandro E., Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011;16(5):e635-e640.
Ziegler D., Ametov A., Barinov A., Dyck P. J., Gurieva I., Low P. A., Munzel U., Yakhno N., Raz I., Novosadova M., Maus J., Samigullin, R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29(11):2365-2370.
Gu X. M., Zhang S. S., Wu J. C., Tang Z. Y., Lu Z. Q., Li H., Liu C., Chen L., Ning, G. [Efficacy and safety of high-dose a-lipoic acid in the treatment of diabetic polyneuropathy]. Zhonghua Yi Xue Za Zhi 2010;90(35):2473-2476.
). Ziegler D., Low P. A., Litchy W. J., Boulton A. J., Vinik A. I., Freeman R., Samigullin R., Tritschler H., Munzel U., Maus J., Schütte K., Dyck P. J. Efficacy and safety of antioxidant treatment with a-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011;34(9):2054-2060.
Ametov A. S., Novosadova M. V., Barinov A. N., Samigullin R., Trischler H. J. [Long-term effect of 3-week intravenous alpha-lipoic acid administration in symptomatic diabetic polyneutropathy with clinical manifestations]. Ter Arkh 2010;82(12):61-64.
Liu F., Zhang Y., Yang M., Liu B., Shen Y. D., Jia W. P., Xiang K. S. [Curative effect of alpha-lipoic acid on peripheral neuropathy in type 2 diabetes: a clinical study]. Zhonghua Yi Xue Za Zhi 2007;87(38):2706-2709.
Haak E., Usadel K. H., Kusterer K., Amini P., Frommeyer R., Tritschler H. J., Haak T. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes 2000;108(3):168-174.
Sadykova H. G., Nazhmutdinova, D. K. [Structural and functional condition of the left ventricle in patients with type 2 diabetes mellitus complicated with diabetic autonomic neuropathy]. Lik Sprava 2009;(1-2):22-28.
Volchegorskii I. A., Alekseev M. N., Volchegorskaia M. I., Rassokhina L. M. [Effect of alpha-lipoic acid and mexidol on neuro- and the affective status in patients at early stages of diabetic foot syndrome]. Klin Med (Mosk) 2008;86(10):52-59.
Tankova T., Koev D., Dakovska, L. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Rom J Intern Med 2004;42(2):457-464.
Jörg J., Metz F., Scharafinski, H. [Drug treatment of diabetic polyneuropathy with alpha-lipoic acid or vitamin B preparations. A clinical and neurophysiologic study]. Nervenarzt 1988;59(1):36-44.
Burekovic A., Terzic M., Alajbegovic S., Vukojevic Z., Hadzic N. The role of alpha-lipoic acid in diabetic polyneuropathy treatment. Bosn J Basic Med Sci 2008;8(4):341-345.
Bertolotto F., Massone A. Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy. Drugs R D 2012;12(1):29-34.
Ranieri M., Sciuscio M., Cortese A. M., Santamato A., Di Teo L., Ianieri G., Bellomo R. G., Stasi M., Megna M. The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life. Int J Immunopathol Pharmacol 2009;22(3 Suppl):45-50.
Porasuphatana S., Suddee S., Nartnampong A., Konsil J., Harnwong B., Santaweesuk A. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Asia Pac J Clin Nutr 2012;21(1):12-21.
Haritoglou C., Gerss J., Hammes H. P., Kampik A., Ulbig M. W. Alpha-lipoic acid for the prevention of diabetic macular edema. Ophthalmologica 2011;226(3):127-137.
Ansar H., Mazloom Z., Kazemi F., Hejazi N. Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 2011;32(6):584-588.
de Oliveira A. M., Rondó P. H., Luzia L. A., D'Abronzo F. H., Illison V. K. The effects of lipoic acid and a-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Diabetes Res Clin Pract 2011;92(2):253-260.
Mazloom Z., Ansar H. The Effect of Alpha-Lipoic Acid on Blood Pressure in Type 2 Diabetics. Iranian Journal of Endocrinology and Metabolism 2009;11(3):245-250.
Volchegorskii I. A., Rassokhina L. M., Koliadich M. I., Alekseev M. I. [Comparative study of alpha-lipoic acid and mexidol effects on affective status, cognitive functions and quality of life in diabetes mellitus patients]. Eksp Klin Farmakol 2011;74(11):17-23.
Du X., Edelstein D., Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 2008;51(10):1930-1932.
Baillie J. K., Thompson A. A., Irving J. B., Bates M. G., Sutherland A. I., Macnee W., Maxwell S. R., Webb D. J. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. QJM 2009;102(5):341-348.
Hager K., Kenklies M., McAfoose J., Engel J., Münch G. Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis. J Neural Transm Suppl 2007;(72):189-193.
Lott I. T., Doran E., Nguyen V. Q., Tournay A., Head E., Gillen D. L. Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. Am J Med Genet A 2011;155A(8):1939-1948.
Filina A. A., Davydova N. G., Endrikhovskii S. N., Shamshinova A. M. [Lipoic acid as a means of metabolic therapy of open-angle glaucoma]. Vestn Oftalmol 1995;111(4):6-8.
Leong J. Y., van der Merwe J., Pepe S., Bailey M., Perkins A., Lymbury R., Esmore D., Marasco S., Rosenfeldt F. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial. Heart Lung Circ 2010;19(10):584-591.
Di Geronimo G., Caccese A. F., Caruso L., Soldati A., Passaretti U. Treatment of carpal tunnel syndrome with alpha-lipoic acid. Eur Rev Med Pharmacol Sci 2009;13(2):133-139.
Jariwalla R. J., Lalezari J., Cenko D., Mansour S. E., Kumar A., Gangapurkar B., Nakamura D. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection. J Altern Complement Med 2008;14(2):139-146.
Rahman S. T., Merchant N., Haque T., Wahi J., Bhaheetharan S., Ferdinand K. C., Khan B. V. The impact of lipoic acid on endothelial function and proteinuria in quinapril-treated diabetic patients with stage I hypertension: results from the QUALITY study. J Cardiovasc Pharmacol Ther 2012;17(2):139-145.
Zhang Y., Han P., Wu N., He B., Lu Y., Li S., Liu Y., Zhao S., Liu L., Li Y. Amelioration of lipid abnormalities by a-lipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 2011;19(8):1647-1653.
Khabbazi T., Mahdavi R., Safa J., Pour-Abdollahi P. Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr 2012;22(2):244-250.
Chang J. W., Lee E. K., Kim T. H., Min W. K., Chun S., Lee K. U., Kim S. B., Park J. S. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. Am J Nephrol 2007;27(1):70-74.
Magis D., Ambrosini A., Sandor P., Jacquy J., Laloux P., Schoenen J. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis. Headache 2007;47(1):52-57.
Carbone M., Pentenero M., Carrozzo M., Ippolito A., Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009;13(5):492-496.
López-Jornet P., Camacho-Alonso F., and Leon-Espinosa, S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil 2009;36(1):52-57.
Marino R., Torretta S., Capaccio P., Pignataro L., Spadari F. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med 2010;39(8):611-616.
Cavalcanti D. R., da Silveira F. R. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009;38(3):254-261.
Femiano F., Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002;31(5):267-269.
Femiano F., Gombos F., Scully C. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004;9(1):8-13.
Femiano F., Gombos F., Scully C., Busciolano M., Luca P. D. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000;6(5):274-277.
Femiano F., Gombos F., Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 2004;18(6):676-678.
Korkina L. G., Afanas'ef I. B., Diplock A. T. Antioxidant therapy in children affected by irradiation from the Chernobyl nuclear accident. Biochem Soc Trans 1993;21 ( Pt 3)(3):314S.
Bae S. C., Jung W. J., Lee E. J., Yu R., Sung M. K. Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 2009;28(1):56-62.
Memeo A., Loiero M. Thioctic acid and acetyl-L-carnitine in the treatment of sciatic pain caused by a herniated disc: a randomized, double-blind, comparative study. Clin Drug Investig 2008;28(8):495-500.
Thom E. A randomized, double-blind, placebo-controlled study on the clinical efficacy of oral treatment with DermaVite on ageing symptoms of the skin. J Int Med Res 2005;33(3):267-272.
Podymova S. D., Davletshina I. V. [Efficacy of using alpha-lipoic acid (berlition) in patients with nonalcoholic steatohepatitis]. Eksp Klin Gastroenterol 2008;(5):77-84.
Koh E. H., Lee W. J., Lee S. A., Kim E. H., Cho E. H., Jeong E., Kim D. W., Kim M. S., Park J. Y., Park K. G., Lee H. J., Lee I. K., Lim S., Jang H. C., Lee K. H., Lee K. U. Effects of alpha-lipoic Acid on body weight in obese subjects. Am J Med 2011;124(1):85-88.
Alleva R., Tomasetti M., Sartini D., Emanuelli M., Nasole E., Di Donato F., Borghi B., Santarelli L., Neuzil J. alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy. Mol Med 2008;14(3-4):175-183.
Alleva R., Nasole E., Di Donato F., Borghi B., Neuzil J., Tomasetti M. alpha-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem Biophys Res Commun 2005;333(2):404-410.
Schimmelpfennig W, Renger F, Wack R, et al. [Results of a prospective double-blind study with alpha-lipoic acid against placebo in alcoholic liver damage] (Ergebnisse einer prospektiven Doppelblindstudie mit Alpha-Liponsäure gegen Plazebo bei alkoholischen Leberschäden). Dtsch Gesundheitswes 1983;38(18):690-693
Rees-Jones RW, Larsen PR. Triiodothyronine and thyroxine content of desiccated thyroid tablets. Metabolism 1977;26(11):1213-1218.
Lee, T. and Dugoua, J. J. Nutritional supplements and their effect on glucose control. Curr.Diab.Rep. 2011;11(2):142-148.
Breithaupt-Grogler, K., Niebch, G., Schneider, E., Erb, K., Hermann, R., Blume, H. H., Schug, B. S., and Belz, G. G. Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci 1999;8(1):57-65.
Khanna, S., Atalay, M., Laaksonen, D. E., Gul, M., Roy, S., and Sen, C. K. Alpha-lipoic acid supplementation: tissue glutathione homeostasis at rest and after exercise. J Appl.Physiol 1999;86(4):1191-1196.
Mitsui, Y., Schmelzer, J. D., Zollman, P. J., Mitsui, M., Tritschler, H. J., and Low, P. A. Alpha-lipoic acid provides neuroprotection from ischemia-reperfusion injury of peripheral nerve. J Neurol.Sci. 2-1-1999;163(1):11-16.
Haak, E. S., Usadel, K. H., Kohleisen, M., Yilmaz, A., Kusterer, K., and Haak, T. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. Microvasc.Res. 1999;58(1):28-34.
Borcea, V., Nourooz-Zadeh, J., Wolff, S. P., Klevesath, M., Hofmann, M., Urich, H., Wahl, P., Ziegler, R., Tritschler, H., Halliwell, B., and Nawroth, P. P. alpha-Lipoic acid decreases oxidative stress even in diabetic patients with poor glycemic control and albuminuria. Free Radic.Biol.Med. 1999;22(11-12):1495-1500.
Ziegler, D., Reljanovic, M., Mehnert, H., and Gries, F. A. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol.Diabetes 1999;107(7):421-430.
Yaworsky, K., Somwar, R., Ramlal, T., Tritschler, H. J., and Klip, A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia 2000;43(3):294-303.
Jain, S. K. and Lim, G. Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose- treated human erythrocytes. Free Radic.Biol.Med 2000;29(11):1122-1128.
Bailey, D. M. and Davies, B. Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2001;2(1):21-29.
Morcos, M., Borcea, V., Isermann, B., Gehrke, S., Ehret, T., Henkels, M., Schiekofer, S., Hofmann, M., Amiral, J., Tritschler, H., Ziegler, R., Wahl, P., and Nawroth, P. P. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract 2001;52(3):175-183.
Konrad, D., Somwar, R., Sweeney, G., Yaworsky, K., Hayashi, M., Ramlal, T., and Klip, A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes 2001;50(6):1464-1471.
Heitzer, T., Finckh, B., Albers, S., Krohn, K., Kohlschutter, A., and Meinertz, T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic.Biol Med 7-1-2001;31(1):53-61.
Evans, J. L., Heymann, C. J., Goldfine, I. D., and Gavin, L. A. Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of alpha-lipoic acid. Endocr.Pract. 2002;8(1):29-35.
Femiano, F. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol. 2002;51(9):405-409.
Mantovani, G., Maccio, A., Madeddu, C., Mura, L., Gramignano, G., Lusso, M. R., Massa, E., Mocci, M., and Serpe, R. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med 2003;81(10):664-673.
Teichert, J., Hermann, R., Ruus, P., and Preiss, R. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers. J Clin Pharmacol 2003;43(11):1257-1267.
Smith, A. R. and Hagen, T. M. Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid. Biochem Soc Trans. 2003;31(Pt 6):1447-1449.
Hahm, J. R., Kim, B. J., and Kim, K. W. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients. J Diabetes Complications 2004;18(2):79-85.
Kravchuk, IuA, Mekhtiev, S. N., Uspenskii, IuP, Grinevich, V. B., and Koblov, S. V. [Device laboratory and postmortem parallels in alcoholic hepatitis during combined therapy using thioctic (alpha-lipoic) acid]. Klin.Med (Mosk) 2004;82(6):55-57.
Jang, W. G., Kim, H. S., Park, K. G., Park, Y. B., Yoon, K. H., Han, S. W., Hur, S. H., Park, K. S., and Lee, I. K. Analysis of proteome and transcriptome of tumor necrosis factor alpha stimulated vascular smooth muscle cells with or without alpha lipoic acid. Proteomics. 2004;4(11):3383-3393.
Bruckner, I., Bustan, C., Adamescu, E., and Dobjanschi, C. Diabetic neuropathy--choices of treatment. Rom.J Intern Med 2002;40(1-4):53-60.
Negrisanu, G., Rosu, M., Bolte, B., Lefter, D., and Dabelea, D. Effects of 3-month treatment with the antioxidant alpha-lipoic acid in diabetic peripheral neuropathy. Rom.J Intern Med 1999;37(3):297-306.
Doggrell, S. A. Alpha-lipoic acid, an anti-obesity agent? Expert.Opin.Investig.Drugs 2004;13(12):1641-1643.
Sola, S., Mir, M. Q., Cheema, F. A., Khan-Merchant, N., Menon, R. G., Parthasarathy, S., and Khan, B. V. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 1-25-2005;111(3):343-348.
Zakrzewska, J. M., Forssell, H., and Glenny, A. M. Interventions for the treatment of burning mouth syndrome. Cochrane.Database.Syst Rev 2005;(1):CD002779.
Wenzel, U., Nickel, A., and Daniel, H. alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation. Apoptosis. 2005;10(2):359-368.
Gregus, Z., Stein, A. F., Varga, F., and Klaassen, C. D. Effect of lipoic acid on biliary excretion of glutathione and metals. Toxicol Appl Pharmacol 1992;114(1):88-96.
Lee, W. J., Song, K. H., Koh, E. H., Won, J. C., Kim, H. S., Park, H. S., Kim, M. S., Kim, S. W., Lee, K. U., and Park, J. Y. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem.Biophys.Res Commun. 7-8-2005;332(3):885-891.
Tankova, T., Cherninkova, S., and Koev, D. Treatment for diabetic mononeuropathy with alpha-lipoic acid. Int J Clin.Pract. 2005;59(6):645-650.
Koh, J. M., Lee, Y. S., Byun, C. H., Chang, E. J., Kim, H., Kim, Y. H., Kim, H. H., and Kim, G. S. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells. J Endocrinol. 2005;185(3):401-413.
Byun, C. H., Koh, J. M., Kim, D. K., Park, S. I., Lee, K. U., and Kim, G. S. alpha-Lipoic Acid Inhibits TNF-alpha-Induced Apoptosis in Human Bone Marrow Stromal Cells. J Bone Miner.Res 2005;20(7):1125-1135.
Sung, M. J., Kim, W., Ahn, S. Y., Cho, C. H., Koh, G. Y., Moon, S. O., Kim, D. H., Lee, S., Kang, K. P., Jang, K. Y., and Park, S. K. Protective effect of alpha-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ.Res 10-28-2005;97(9):880-890.
Lee, W. J., Lee, I. K., Kim, H. S., Kim, Y. M., Koh, E. H., Won, J. C., Han, S. M., Kim, M. S., Jo, I., Oh, G. T., Park, I. S., Youn, J. H., Park, S. W., Lee, K. U., and Park, J. Y. Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler.Thromb.Vasc.Biol 2005;25(12):2488-2494.
Bregovskii, V. B., Posokhina, O. V., and Karpova, I. A. [Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs]. Ter.Arkh. 2005;77(10):15-19.
Tarnopolsky, M. A. and Raha, S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc. 2005;37(12):2086-2093.
Berkson, B. M., Rubin, D. M., and Berkson, A. J. The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol. Integr.Cancer Ther 2006;5(1):83-89.
Mantovani, G., Maccio, A., Madeddu, C., Gramignano, G., Lusso, M. R., Serpe, R., Massa, E., Astara, G., and Deiana, L. A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol.Biomarkers Prev. 2006;15(5):1030-1034.
Bergqvist-Karlsson, A., Thelin, I., and Bergendorff, O. Contact dermatitis to alpha-lipoic acid in an anti-wrinkle cream. Contact Dermatitis 2006;55(1):56-57.
Suarez, P. and Clark, G. T. Burning mouth syndrome: an update on diagnosis and treatment methods. J Calif.Dent.Assoc. 2006;34(8):611-622.
Jameel, N. M., Shekhar, M. A., and Vishwanath, B. S. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity. Life Sci 12-14-2006;80(2):146-153.
Dunschede, F., Erbes, K., Kircher, A., Westermann, S., Seifert, J., Schad, A., Oliver, K., Kiemer, A. K., and Theodor, J. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by alpha-lipoic acid in humans. World J Gastroenterol 11-14-2006;12(42):6812-6817.
Kamenova, P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones.(Athens.) 2006;5(4):251-258.
Zhang, W. J., Wei, H., Hagen, T., and Frei, B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci U.S.A 3-6-2007;104(10):4077-4082.
Rooney, J. P. The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxicology 5-20-2007;234(3):145-156.
Tang, J., Wingerchuk, D. M., Crum, B. A., Rubin, D. I., and Demaerschalk, B. M. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist. 2007;13(3):164-167.
McCormick, R. K. Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Altern.Med Rev. 2007;12(2):113-145.
Moreira, P. I., Harris, P. L., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., and Perry, G. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers.Dis 2007;12(2):195-206.
Zembron-Lacny, A., Szyszka, K., and Szygula, Z. Effect of cysteine derivatives administration in healthy men exposed to intense resistance exercise by evaluation of pro-antioxidant ratio. J Physiol Sci 2007;57(6):343-348.
Janson, M. Orthomolecular medicine: the therapeutic use of dietary supplements for anti-aging. Clin Interv.Aging 2006;1(3):261-265.
Mignini, F., Streccioni, V., Tomassoni, D., Traini, E., and Amenta, F. Comparative crossover, randomized, open-label bioequivalence study on the bioequivalence of two formulations of thioctic acid in healthy volunteers. Clin Exp.Hypertens. 2007;29(8):575-586.
Xiang, G. D., Sun, H. L., Zhao, L. S., Hou, J., Yue, L., and Xu, L. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol.(Oxf) 2008;68(5):716-723.
Huang, E. A. and Gitelman, S. E. The effect of oral alpha-lipoic acid on oxidative stress in adolescents with type 1 diabetes mellitus. Pediatr.Diabetes 2008;9(3 Pt 2):69-73.
Mantovani, G., Maccio, A., Madeddu, C., Gramignano, G., Serpe, R., Massa, E., Dessi, M., Tanca, F. M., Sanna, E., Deiana, L., Panzone, F., Contu, P., and Floris, C. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 2008;24(4):305-313.
Kim, E., Park, D. W., Choi, S. H., Kim, J. J., and Cho, H. S. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia. J Clin Psychopharmacol. 2008;28(2):138-146.
Al'-Zamil', M. K. and Brezheva, E. V. [Implication of alpha-lipoic acid preparations in the treatment of diabetic neuropathy]. Zh.Nevrol.Psikhiatr.Im S.S.Korsakova 2008;108(2):27-30.
Ghibu, S., Richard, C., Delemasure, S., Vergely, C., Mogosan, C., and Muresan, A. [An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases]. Ann Cardiol.Angeiol.(Paris) 2008;57(3):161-165.
Wray, D. W., Uberoi, A., Lawrenson, L., Bailey, D. M., and Richardson, R. S. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome. Clin Sci (Lond) 2009;116(5):433-441.
Hatzitolios, A., Iliadis, F., Katsiki, N., and Baltatzi, M. Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review. Clin Exp.Hypertens. 2008;30(7):628-639.
Bangma, H. R., Smit, G. P., Kuks, J. B., Grevink, R. G., and Wolffenbuttel, B. H. [Two patients with mitochondrial respiratory chain disease]. Ned.Tijdschr.Geneeskd. 10-18-2008;152(42):2298-2301.
Singh, U. and Jialal, I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev. 2008;66(11):646-657. [RETRACTED].
Spisakova, M., Cizek, Z., and Melkova, Z. Ethacrynic and alpha-lipoic acids inhibit vaccinia virus late gene expression. Antiviral Res 2009;81(2):156-165.
Bartlett, H. E. and Eperjesi, F. Nutritional supplementation for type 2 diabetes: a systematic review. Ophthalmic Physiol Opt. 2008;28(6):503-523.
Zembron-Lacny, A., Slowinska-Lisowska, M., Szygula, Z., Witkowski, K., and Szyszka, K. The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males. Physiol Res 2009;58(6):855-861.
Statsenko, M. E., Poletaeva, L. V., Turkina, S. V., Apukhtin, A. F., and Dudchenko, G. P. [Mildronate effects on oxidant stress in type 2 diabetic patients with diabetic peripheral (sensomotor) neuropathy]. Ter.Arkh. 2008;80(10):27-30.
Martins, V. D., Manfredini, V., Peralba, M. C., and Benfato, M. S. Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients. Clin Nutr 2009;28(2):192-197.
Sun-Edelstein, C. and Mauskop, A. Foods and supplements in the management of migraine headaches. Clin J Pain 2009;25(5):446-452.
Zembron-Lacny, A., Slowinska-Lisowska, M., Szygula, Z., Witkowski, K., Stefaniak, T., and Dziubek, W. Assessment of the antioxidant effectiveness of alpha-lipoic acid in healthy men exposed to muscle-damaging exercise. J Physiol Pharmacol. 2009;60(2):139-143.
Harris, R. A., Nishiyama, S. K., Wray, D. W., Tedjasaputra, V., Bailey, D. M., and Richardson, R. S. The effect of oral antioxidants on brachial artery flow-mediated dilation following 5 and 10 min of ischemia. Eur J Appl.Physiol 2009;107(4):445-453.
Rivinius, C. Burning mouth syndrome: Identification, diagnosis, and treatment. J Am Acad.Nurse Pract. 2009;21(8):423-429.
Rutkove, S. B. A 52-year-old woman with disabling peripheral neuropathy: review of diabetic polyneuropathy. JAMA 10-7-2009;302(13):1451-1458.
Wray, D. W., Nishiyama, S. K., Monnet, A., Wary, C., Duteil, S. S., Carlier, P. G., and Richardson, R. S. Antioxidants and aging: NMR-based evidence of improved skeletal muscle perfusion and energetics. Am J Physiol Heart Circ.Physiol 2009;297(5):H1870-H1875.
Gianturco, V., Bellomo, A., D'Ottavio, E., Formosa, V., Iori, A., Mancinella, M., Troisi, G., and Marigliano, V. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch.Gerontol.Geriatr. 2009;49 Suppl 1:129-133.
Lee, S. H., Kim, M. J., Kim, B. J., Kim, S. R., Chun, S., Ryu, J. S., Kim, G. S., Lee, M. C., Koh, J. M., and Chung, S. J. Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease. Mov Disord. 2-15-2010;25(3):332-340.
Donato, A. J., Uberoi, A., Bailey, D. M., Wray, D. W., and Richardson, R. S. Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly men. Am J Physiol Heart Circ.Physiol 2010;298(2):H671-H678.
Mittermayer, F., Pleiner, J., Francesconi, M., and Wolzt, M. Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus. Transl.Res 2010;155(1):6-9.
Zembron-Lacny, A., Ostapiuk, J., and Szyszka, K. Effects of sulphur-containing compounds on plasma redox status in muscle-damaging exercise. Chin J Physiol 10-31-2009;52(5):289-294.
Berkson, B. M., Rubin, D. M., and Berkson, A. J. Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases. Integr Cancer Ther 2009;8(4):416-422.
Heinisch, B. B., Francesconi, M., Mittermayer, F., Schaller, G., Gouya, G., Wolzt, M., and Pleiner, J. Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial. Eur J Clin Invest 2010;40(2):148-154.
Fedin, A. I., Kuznetsov, M. R., Beresten', N. F., Kuznetsova, V. F., Kholopova, E. A., Ibragimov, T. M., Tugdumov, B. V., and Dubrovin, E. E. [Correction of disordered cerebral blood flow autoregulation in atherosclerosis]. Angiol.Sosud.Khir. 2009;15(3):21-26.
Xiang GD, Pu JH, Snu HL, and Zhao LS. Alpha-lipoic acid improves endothelial dysfunction in patients with subclinical hypothyroidism. Exp.Clin Endocrinol.Diabetes 2010;118(9):625-629.
Skalska, S., Kucera, P., Goldenberg, Z., Stefek, M., Kyselova, Z., Jariabka, P., Gajdosikova, A., Klobucnikova, K., Traubner, P., and Stolc, S. Neuropathy in a rat model of mild diabetes induced by multiple low doses of streptozotocin: effects of the antioxidant stobadine in comparison with a high-dose alpha-lipoic acid treatment. Gen.Physiol Biophys 2010;29(1):50-58.
Mijnhout, G. S., Alkhalaf, A., Kleefstra, N., and Bilo, H. J. Alpha lipoic acid: a new treatment for neuropathic pain in patients with diabetes? Neth.J Med 2010;68(4):158-162.
Cagini, C., Leontiadis, A., Ricci, M. A., Bartolini, A., Dragoni, A., and Pellegrino, R. M. Study of alpha-lipoic acid penetration in the human aqueous after topical administration. Clin Experiment.Ophthalmol. 2010;38(6):572-576.
Najm, W. and Lie, D. Herbals used for diabetes, obesity, and metabolic syndrome. Prim.Care 2010;37(2):237-254.
Palacka, P., Kucharska, J., Murin, J., Dostalova, K., Okkelova, A., Cizova, M., Waczulikova, I., Moricova, S., and Gvozdjakova, A. Complementary therapy in diabetic patients with chronic complications: a pilot study. Bratisl.Lek.Listy 2010;111(4):205-211.
Salinthone, S., Yadav, V., Schillace, R. V., Bourdette, D. N., and Carr, D. W. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS.One. 2010;5(9)
Guais, A., Baronzio, G., Sanders, E., Campion, F., Mainini, C., Fiorentini, G., Montagnani, F., Behzadi, M., Schwartz, L., and Abolhassani, M. Adding a combination of hydroxycitrate and lipoic acid (METABLOC) to chemotherapy improves effectiveness against tumor development: experimental results and case report. Invest New Drugs 2012;30(1):200-211.
Milazzo, L., Menzaghi, B., Caramma, I., Nasi, M., Sangaletti, O., Cesari, M., Zanone, Poma B., Cossarizza, A., Antinori, S., and Galli, M. Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study. AIDS Res.Hum.Retroviruses 2010;26(11):1207-1214.
Ramos, L. F., Kane, J., McMonagle, E., Le, P., Wu, P., Shintani, A., Ikizler, T. A., and Himmelfarb, J. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr 2011;21(3):211-218.
Xiang, G., Pu, J., Yue, L., Hou, J., and Sun, H. alpha-lipoic acid can improve endothelial dysfunction in subjects with impaired fasting glucose. Metabolism 2011;60(4):480-485.
Becker, S., Schmidt, C., Berghaus, A., Tschiesner, U., Olzowy, B., and Reichel, O. Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study. Eur Arch.Otorhinolaryngol. 2011;268(9):1375-1381.
Lopez-Erauskin, J., Fourcade, S., Galino, J., Ruiz, M., Schluter, A., Naudi, A., Jove, M., Portero-Otin, M., Pamplona, R., Ferrer, I., and Pujol, A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol. 2011;70(1):84-92.
Nebbioso, M., Federici, M., Rusciano, D., Evangelista, M., and Pescosolido, N. Oxidative stress in preretinopathic diabetes subjects and antioxidants. Diabetes Technol.Ther 2012;14(3):257-263.
Madeddu, C., Dessi, M., Panzone, F., Serpe, R., Antoni, G., Cau, M. C., Montaldo, L., Mela, Q., Mura, M., Astara, G., Tanca, F. M., Maccio, A., and Mantovani, G. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Clin Nutr 2012;31(2):176-182.
de, Moraes M., do Amaral Bezerra, B. A., da Rocha Neto, P. C., de Oliveira Soares, A. C., Pinto, L. P., and de Lisboa Lopes, Costa A. Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature. J Oral Pathol.Med. 2012;41(4):281-287.
McNeilly, A. M., Davison, G. W., Murphy, M. H., Nadeem, N., Trinick, T., Duly, E., Novials, A., and McEneny, J. Effect of alpha-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. Lipids Health Dis 2011;10:217.
Mollo, R., Zaccardi, F., Scalone, G., Scavone, G., Rizzo, P., Navarese, E. P., Manto, A., Pitocco, D., Lanza, G. A., Ghirlanda, G., and Crea, F. Effect of alpha-lipoic acid on platelet reactivity in type 1 diabetic patients. Diabetes Care 2012;35(2):196-197.
Rosa, F. T., Zulet, M. A., Marchini, J. S., and Martinez, J. A. Bioactive compounds with effects on inflammation markers in humans. Int J Food Sci Nutr 2012;63(6):749-765.
Wray, D. W., Nishiyama, S. K., Harris, R. A., Zhao, J., McDaniel, J., Fjeldstad, A. S., Witman, M. A., Ives, S. J., Barrett-O'Keefe, Z., and Richardson, R. S. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension 2012;59(4):818-824.
Pfeffer, G., Majamaa, K., Turnbull, D. M., Thorburn, D., and Chinnery, P. F. Treatment for mitochondrial disorders. Cochrane Database.Syst.Rev. 2012;4:CD004426.
Tsai, F. J., Wang, Y. D., Chen, C. C., Hsieh, C., Cheng, Z. J., and Wu, Y. J. Evaluation of the antioxidative capability of commonly used antioxidants in dermocosmetics by in vivo detection of protein carbonylation in human stratum corneum. J Photochem.Photobiol.B 7-2-2012;112:7-15.
Chaparro, L. E., Wiffen, P. J., Moore, R. A., and Gilron, I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database.Syst.Rev. 2012;7:CD008943.
Larkin, J., Bea, L., and Sharma, A. A cost effective complement to managing the vitamin D deficient and anemic dialysis patient in the bundled world. Nephrol.News Issues 2012;26(8):22-4, 26.
Scholich, H., Murphy, M. E., and Sies, H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on alpha-tocopherol. Biochim.Biophys Acta 2-20-1989;1001(3):256-261.
Ou, P., Tritschler, H. J., and Wolff, S. P. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem.Pharmacol. 6-29-1995;50(1):123-126.
Constantinescu, A., Pick, U., Handelman, G. J., Haramaki, N., Han, D., Podda, M., Tritschler, H. J., and Packer, L. Reduction and transport of lipoic acid by human erythrocytes. Biochem.Pharmacol. 7-17-1995;50(2):253-261.
Maitra, I., Serbinova, E., Trischler, H., and Packer, L. Alpha-lipoic acid prevents buthionine sulfoximine-induced cataract formation in newborn rats. Free Radic.Biol.Med 1995;18(4):823-829.
Muller, U. and Krieglstein, J. Prolonged pretreatment with alpha-lipoic acid protects cultured neurons against hypoxic, glutamate-, or iron-induced injury. J Cereb.Blood Flow Metab 1995;15(4):624-630.
Podda, M., Tritschler, H. J., Ulrich, H., and Packer, L. Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem.Biophys.Res.Commun. 10-14-1994;204(1):98-104.
Kawabata, T. and Packer, L. Alpha-lipoate can protect against glycation of serum albumin, but not low density lipoprotein. Biochem.Biophys.Res.Commun. 8-30-1994;203(1):99-104.
Handelman, G. J., Han, D., Tritschler, H., and Packer, L. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem Pharmacol 5-18-1994;47(10):1725-1730.
Kahler, W., Kuklinski, B., Ruhlmann, C., and Plotz, C. [Diabetes mellitus--a free radical-associated disease. Results of adjuvant antioxidant supplementation]. Z Gesamte Inn.Med 1993;48(5):223-232.
Jacob, S., Streeper, R. S., Fogt, D. L., Hokama, J. Y., Tritschler, H. J., Dietze, G. J., and Henriksen, E. J. The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 1996;45(8):1024-1029.
Gleiter, C. H., Schug, B. S., Hermann, R., Elze, M., Blume, H. H., and Gundert-Remy, U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur.J Clin Pharmacol. 1996;50(6):513-514.
Estrada, D. E., Ewart, H. S., Tsakiridis, T., Volchuk, A., Ramlal, T., Tritschler, H., and Klip, A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes 1996;45(12):1798-1804.
Henriksen, E. J., Jacob, S., Streeper, R. S., Fogt, D. L., Hokama, J. Y., and Tritschler, H. J. Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci 1997;61(8):805-812.
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., Wahl, P., Ziegler, R., and Nawroth, P. P. Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 1997;46(9):1481-1490.
Han, D., Sen, C. K., Roy, S., Kobayashi, M. S., Tritschler, H. J., and Packer, L. Protection against glutamate-induced cytotoxicity in C6 glial cells by thiol antioxidants. Am J Physiol 1997;273(5 Pt 2):R1771-R1778.
Eremeeva, M. E. and Silverman, D. J. Effects of the antioxidant alpha-lipoic acid on human umbilical vein endothelial cells infected with Rickettsia rickettsii. Infect.Immun. 1998;66(5):2290-2299.
Khanna, S., Atalay, M., Lodge, J. K., Laaksonen, D. E., Roy, S., Hanninen, O., Packer, L., and Sen, C. K. Skeletal muscle and liver lipoyllysine content in response to exercise, training and dietary alpha-lipoic acid supplementation. Biochem.Mol.Biol.Int. 1998;46(2):297-306.
Rett K, Wicklmayr M, Ruus P, and et al. Lipoic acid acutely ameliorates insulin sensitivity in obese subjects with type 2 diabetes. Diabetes Und Stoffwechsel 1996;5(3 suppl):59-63.
Reichel G, Doberenz M, Both R, and et al. Function of cardiac nerves in diabetics during alpha-lipoic-acid-therapy. J Neurol Sci 1997;150(5):S209.
Lukaszuk, J. Schultz T. Prawitz A. and Hofmann E. R-Alpha Lipoic Acid Effect on HbA1c in Type-2 Diabetics. Journal of Complementary and Integrative Medicine 2009;6(1):1-14.
Mazloom, Z. and Ansar H. The Effect of Alpha-Lipoic Acid on Blood Pressure in Type 2 Diabetics. Iranian Journal of Endocrinology and Metabolism 2009;11(3):245-250.
Kieburtz K, Schifitto G, McDermott M, and et al. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 1998;50(3):645-651.
Schimmelpfennig W, Renger F, Wack R, and et al. [Results of a prospective double-blind study with alpha-lipoic acid against placebo in alcoholic liver damage] (Ergebnisse einer prospektiven Doppelblindstudie mit Alpha-Liponsäure gegen Plazebo bei alkoholischen Leberschäden). Dtsch Gesundheitswes 1983;38(18):690-693.
Evans, JL and Goldfine, ID. Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technology and Therapeutics 2000;2(3):401-413.
Zhao YY. Combined therapeutic effects of -lipoic acid and mecobalamin on diabetic peripheral neuropathy. Journal of Practical Training of Medicine 2008;24:4289-4290.
Zou JJ, Zheng JY Zhao Y Tang W Shi YQ & Liu ZM. Effects and safety of combined therapy of -lipoic acid, mecobalamin and prostaglandin E1 for diabetic peripheral neuropathy. Shanghai Medical Journal 2008;31:364-365.
Huang H, Zhu KS Wang P Qu JC Ji XF & Song M. The effects of lipoic acid and prostaglandin E1 on diabetic peripheral neuropathy. Chinese Journal of Clinical Health 2008;11:29-30.
Zhang XL, Feng YL Zhou BA & Wei GY. Effects of mecobalamin and -lipoic acid on diabetic peripheral neuropathy. Journal of Traditional Chinese Medicine. 2009;24:1104-1105.
Suo LN & Zhang D. Effects of lipoic acid and mecobalamin on diabetic peripheral neuropathy. Journal of Traditional Chinese Medicine. 2009;24:1104-1105.
Li J, Xu QL. Effects of shuxuening and -lipoic acid on diabetic peripheral neuropathy. Journal of Modern Drug Application. 2008;2:49-50.
Wang J, Song W Huang J & Qu YC. Effects of prostaglandin E1 and -lipoic acid on diabetic peripheral neuropathy. Journal of Practical Training of Medicine 2007;23:1325-1326.
Wu YX, Shi F & Ling L. Effects of lipoic acid and prostaglandin E1on diabetic peripheral neuropathy. Journal of Sun Yat-sen University. 2008;29(S3):124-126.
Fu Y. Effects of alpha lipoic acid and mecobalamin on diabetic peripheral neuropathy. Chinese Journal of Practical Internal Medicine. 2008;28:81-83.
Xia W, Zhang L & Wen SL. Effects of alpha-lipoic acid on painful neuropathy of type 2 diabetes. Journal of Henan University. 2008;27:53-54.
Chen LY, Zhang YD & Zhu FY. Effects of alpha lipoic acid and prostaglandin E1 on diabetic peripheral neuropathy. Journal of Practical Diabetology 2008;4:50-51.
Lu YH. Observation of -lipoic acid and ligutrazine curing diabetic peripheral neuropathy. Medical Recapitulate 2009;2:62.
Qiao YC. Effects of lipoic acid on diabetic peripheral neuropathy. Chinese Journal of Clinical Rational Drug Use. 2009;2:62.
Zhou L. Effects of cilostazol and -lipoic acid on diabetic peripheral neuropathy. Journal of Medicine and Health Care. 2009;17:10-11.
VIATRIS GmbH. NATHAN II Study, data on file.
Hager K, Marahrens A, Kenklies M, Riederer P, Munch G. Alpha-lipoic acid as a new treatment option for Azheimer type dementia. Arch Gerontol Geriatr 2001;32(3);275-282.
Guo Y, Jones D, Palmer JL, et al. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. Support Care Cancer 2014;22(5):1223-31.
Letizia Mauro G, Cataldo P, Barbera G, Sanfilippo A. a-Lipoic acid and superoxide dismutase in the management of chronic neck pain: a prospective randomized study. Drugs R D 2014;14(1):1-7.
Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG Jr, Renshaw PF, Cohen BM. A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013 Oct;33(5):627-35.
Cicek M, Yildirir A, Okyay K, et al. Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients. Ren Fail 2013;35(5):748-53.
Hegazy SK, Tolba OA, Mostafa TM, Eid MA, El-Afify DR. Alpha-lipoic acid improves subclinical left ventricular dysfunction in asymptomatic patients with type 1 diabetes. Rev Diabet Stud 2013;10(1):58-67.
Karaarslan U, Isgüder R, Bag Ö, et al. Alpha lipoic acid intoxication, treatment and outcome. Clin Toxicol (Phila) 2013;51(6):522.
Huang Z, Wan X, Liu J, et al. Short-term continuous subcutaneous insulin infusion combined with insulin sensitizers rosiglitazone, metformin, or antioxidant a-lipoic acid in patients with newly diagnosed type 2 diabetes mellitus. Diabetes Technol Ther 2013;15(10):859-69.
Jo SH, Kim SA, Kim HS, et al. Alpha-lipoic acid for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography: the ALIVE study - a prospective randomized trial. Cardiology 2013;126(3):159-66.
Xu Q, Pan J, Yu J, et al. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Res Clin Pract 2013;101(2):99-105.
Emsley R, Chiliza B, Asmal L, du Plessis S, Phahladira L, van Niekerk E, van Rensburg SJ, Harvey BH. A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia. Schizophr Res. 2014 Sep;158(1-3):230-5.
Hong Y, Peng J, Cai X, Zhang X, Liao Y, Lan L. Clinical efficacy of alprostadil combined with alpha-lipoic acid in the treatment of elderly patients with diabetic nephropathy. Open Med (Wars). 2017 Oct 5;12:323-27.
Parente E, Colannino G, Picconi O, Monastra G. Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study. Eur Rev Med Pharmacol Sci. 2017 Sep;21(18):4219-27.
Lee SJ, Jeong SJ, Lee YC, et al. Effects of high-dose alpha-lipoic acid on heart rate variability of type 2 diabetes mellitus patients with cardiac autonomic neuropathy in Korea. Diabetes Metab J. 2017 Aug;41(4):275-83.
Zhang L, Zhang HY, Huang FC, Huang Q, Liu C, Li JR. Study on the clinical value of alprostadil combined with alpha-lipoic acid in treatment of type 2 diabetes mellitus patients with erectile dysfunction. Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3930-33.
Sarezky D, Raquib AR, Dunaief JL, Kim BJ. Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye. Clin Ophthalmol. 2016 Sep 29;10:1899-1903.
Grandi G, Pignatti L, Ferrari F, Dante G, Neri I, Facchinetti F. Vaginal alpha-lipoic acid shows an anti-inflammatory effect on the cervix, preventing its shortening after primary tocolysis. A pilot, randomized, placebo-controlled study. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2243-49.
Tolunay O, Celik T, Komur M, Gezgin AE, Kaya MS, Celik U. A rare cause of status epilepticus: alpha lipoic acid intoxication, case report and review of the literature. Eur J Paediatr Neurol. 2015 Nov;19(6):730-2.
Sanders LLO, de Souza Menezes CE, Chaves Filho AJM, et al. Alpha-lipoic acid as adjunctive treatment for schizophrenia: an open-label trial. J Clin Psychopharmacol. 2017 Dec;37(6):697-701.
Cavestro C, Bedogni G, Molinari F, Mandrino S, Rota E, Frigeri MC. Alpha-lipoic acid shows promise to improve migraine in patients with insulin resistance: a 6-month exploratory study. J Med Food. 2017 Oct 4.
Jurisic-Erzen D, Starcevic-Klasan G, Ivanac D, Peharec S, Girotto D, Jerkovic R. The effects of alpha-lipoic acid on diabetic myopathy. J Endocrinol Invest. 2017 Jun 28.
Namazi N, Larijani B, Azadbakht L. Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials. Clin Nutr. 2017 Jun 8 pii:S0261-5614(17)30212-1.
Kucukgoncu S, Zhou E, Lucas KB, Tek C. Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials. Obes Rev. 2017 May;18(4):594-601.
Boriani F, Granchi D, Roatti G, Merlini L, Sabattini T, Baldini N. Alpha-lipoic acid after median nerve decompression at the carpal tunnel: a randomized controlled trial. J Hand Surg Am. 2017 Apr;42(4):236-42.
Hadzik B, Grass H, Mayatepek E, Daldrup T, Hoehn T. Fata non-accidental alpha-lipoic acid intoxication in an adolescent girl. Klin Padiatr. 2014 Sep;226(5):292-4.
Desideri I, Francolini G, Becherini C, et al. Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera) for chemotherapy-induced peripheral neuropathy management, a prospective study. Med Oncol. 2017 Mar;34(3):46.
Rago R, Gallo M, Dal Lago A, et al. Controlled, prospective, observational study on the efficiency and tolerability of a combination of potential Nrf2-inducing antioxidants and micronutrients as pre-treatment for ICSI in dyspermic patients with previous failure. Eur Rev Med Pharmacol Sci. 2017;21(7):1645-1652.
Sardu C, Santulli G, Santamaria M, et al. Effects of alpha lipoic acid on multiple cytokines and biomarkers and recurrence of atrial fibrillation within 1 year of catheter ablation. Am J Cardiol. 2017;119(9):1382-1386.
Murina F, Graziottin A, Felice R, Gambini D. Alpha lipoic acid plus omega-3 fatty acids for vestibulodynia associated with painful bladder syndrome. J Obstet Gynaecol Can 2017;39(3):131-7.
Li N, Yan W, Hu X, et al. Effects of oral a-lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2017;86(5):680-7.
Karkabounas S, Papadopoulos N, Anastasiadou C, et al. Effects of a-lipoic Acid, carnosine, and thiamine supplementation in obese patients with type 2 diabetes mellitus: A randomized, double-blind study. J Med Food. 2018;21(12):1197-1203.
Sabanovic M, Jasic M, Odobasic A, et al. Alpha lipoic acid reduces symptoms and inflammation biomarkers in patients with chronic hemorrhoidal illness. Int J Vitam Nutr Res 2018;88(5-6):281-90.
Tromba L, Perla FM, Carbotta G, Chiesa C, Pacifico L. Effect of alpha-lipoic acid supplementation on endothelial function and cardiovascular risk factors in overweight/obese youths: a double-blind, placebo-controlled randomized trial. Nutrients 2019;11(2). pii: E375.
Haghighatdoost F, Hariri M. Does alpha-lipoic acid affect lipid profile? A meta-analysis and systematic review on randomized controlled trials. Eur J Pharmacol 2019;847:1-10.
Hosseinpour-Arjmand S, Amirkhizi F, Ebrahimi-Mameghani M. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther 2019;44(2):258-67.
Jiang Z, Tan Z, Meng F, Li X. Curative effects of valsartan alone or combined with alpha-lipoic acid on inflammatory cytokines and renal function in early-stage diabetic kidney disease. J Coll Physicians Surg Pak. 2019;29(10):1009-1011.
Lai S, Petramala L, Muscaritoli M, et al. a-lipoic acid in patients with autosomal dominant polycystic kidney disease. Nutrition. 2020;71:110594.
Murray GL, Colombo J. (r)Alpha lipoic acid is a safe, effective pharmacologic therapy of chronic orthostatic hypotension associated with low sympathetic tone. Int J Angiol. 2019;28(3):188-193.
Fruzzetti F, Fidecicchi T, Palla G, Gambacciani M. Long-term treatment with a-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. Gynecol Endocrinol. 2020;36(2):152-155.
Genazzani AD, Prati A, Marchini F, Petrillo T, Napolitano A, Simoncini T. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecol Endocrinol. 2019;35(12):1088-1093.
Yousefi M, Kavianpour M, Hesami S, Rashidi Nooshabadi M, Khadem Haghighian H. Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial. Gynecol Endocrinol. 2019;35(9):782-786.
Moretti R, Angeletti C, Minora S. Multiple organ failure and shock following acute alpha lipoic acid (ALA) intoxication. Clin Toxicol (Phila). 2019;57(8):749-751.
Bobe G, Michels AJ, Zhang WJ, et al. A randomized controlled trial of long-term (R)-α-lipoic acid supplementation promotes weight loss in overweight or obese adults without altering baseline elevated plasma triglyceride concentrations. J Nutr. 2020: 150(9):2336-2345.
Passiatore M, Perna A, De-Vitis R, Taccardo G. The use of alfa-lipoic acid-R (ALA-R) in patients with mild-moderate carpal tunnel syndrome: A randomised controlled open label prospective study. Malays Orthop J. 2020;14(1):1-6.
Jamshidi K, Abdollahzad H, Nachvak M, Rezaei M, Golpayegani MR, Sharifi Zahabi E. Effects of alpha-lipoic acid supplementation on cardiovascular disease risk factors in ß-thalassemia major patients: A clinical trial crossover study. J Blood Med. 2020;11:131-139.
El Amrousy D, El-Afify D. Effects of alpha lipoic acid as a supplement in obese children and adolescents. Cytokine. 2020;130:155084.
Haghighatdoost F, Gholami A, Hariri M. Alpha-lipoic acid effect on leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2020;76(5):649-657.
Vajdi M, Abbasalizad Farhangi M. Alpha-lipoic acid supplementation significantly reduces the risk of obesity in an updated systematic review and dose response meta-analysis of randomised placebo-controlled clinical trials. Int J Clin Pract. 2020;74(6):e13493.
El-Nahas MR, Elkannishy G, Abdelhafez H, Elkhamisy ET, El-Sehrawy AA. Oral alpha lipoic acid treatment for symptomatic diabetic peripheral neuropathy: A randomized double-blinded placebo-controlled study. Endocr Metab Immune Disord Drug Targets. 2020.
Mohammadshahi M, Zakizadeh E, Ahmadi-Angali K, Ravanbakhsh M, Helli B. The synergic effects of alpha-lipoic acid supplementation and electrical isotonic contraction on anthropometric measurements and the serum levels of VEGF, NO, sirtuin-1, and PGC1-α in obese people undergoing a weight loss diet. Arch Physiol Biochem. 2020:1-7.
Kim BJ, Hunter A, Brucker AJ, et al. Orally administered alpha lipoic acid as a treatment for geographic atrophy: A randomized clinical trial. Ophthalmol Retina. 2020;4(9):889-898.
Fruzzetti F, Benelli E, Fidecicchi T, et al. Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome. Int J Endocrinol. 2020;2020:2901393.
Derosa G, D'Angelo A, Preti P, Maffioli P. Safety and efficacy of alpha lipoic acid during 4 years of observation: A retrospective, clinical trial in healthy subjects in primary prevention. Drug Des Devel Ther. 2020;14:5367-5374.
Fogacci F, Rizzo M, Krogager C, et al. Safety evaluation of a-lipoic acid supplementation: A systematic review and meta-analysis of randomized placebo-controlled clinical studies. Antioxidants (Basel). 2020;9(10):1011.
Isenmann E, Trittel L, Diel P. The effects of alpha lipoic acid on muscle strength recovery after a single and a short-term chronic supplementation - a study in healthy well-trained individuals after intensive resistance and endurance training. J Int Soc Sports Nutr. 2020;17(1):61.
Polat S, Kiliçaslan Ö, Sönmez FT. Alpha-lipoic acid intoxication in an adolescent girl: Case report and review of the literature. Turk Pediatri Ars. 2020;55(3):328-330.
Sun Y, Guan X, Wang H, et al. Randomized clinical trial of combined therapy with oral a-lipoic acid and NB-UVB for nonsegmental stable vitiligo. Dermatol Ther. 2021;34(1):e14610.
Gilron I, Robb S, Tu D, et al. Double-blind, randomized, placebo-controlled crossover trial of alpha-lipoic acid for the treatment of fibromyalgia pain: the IMPALA trial. Pain. 2021;162(2):561-568.
Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking a-lipoic acid. Clin Endocrinol (Oxf). 2014;81(2):204-9.
Yukina M, Nuralieva N, Solovyev M, Troshina E, Vasilyev E. Insulin autoimmune syndrome. Endocrinol Diabetes Metab Case Rep. 2020;2020:19-0159.
Moffa S, Improta I, Rocchetti S, Mezza T, Giaccari A. Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports. Nutrition. 2019;57:1-4.
Izzo V, Greco C, Corradini D, et al. Insulin autoimmune syndrome in an Argentine woman taking a-lipoic acid: A case report and review of the literature. SAGE Open Med Case Rep. 2018;6:2050313X18819601.
Rahmanabadi A , Mahboob S , Amirkhizi F , Hosseinpour-Arjmand S , Ebrahimi-Mameghani M . Oral a-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features. Food Funct. 2019;10(8):4941-4952.
Hakimizad R, Soltani R, Khorvash F, Marjani M, Dastan F. The effect of acetyl-L-carnitine, alpha-lipoic acid, and coenzyme Q10 combination in preventing anti-tuberculosis drug-induced hepatotoxicity: a randomized, double-blind, placebo-controlled clinical trial. Iran J Pharm Res 2021;20(3):431-40.
Mahmoudinezhad M, Farhangi MA. Alpha lipoic acid supplementation affects serum lipids in a dose and duration-dependent manner in different health status. Int J Vitam Nutr Res 2021.
Vakali E, Rigopoulos D, Carrillo AE, Flouris AD, Dinas PC. Effects of alpha-lipoic acid supplementation on human diabetic nephropathy: A systematic review and meta-analysis. Curr Diabetes Rev 2021.
Esposito C, Ugo Garzarella E, Santarcangelo C, et al. Safety and efficacy of alpha-lipoic acid oral supplementation in the reduction of pain with unknown etiology: A monocentric, randomized, double-blind, placebo-controlled clinical trial. Biomed Pharmacother 2021;144:112308.
Sharifi-Zahabi E, Abdollahzad H, Mostafa Nachvak S, et al. Effects of alpha lipoic acid on iron overload, lipid profile and oxidative stress indices in ß-thalassemia major patients: A cross-over randomised controlled clinical trial. Int J Clin Pract 2021;75(6):e14062.
Rezaei Kelishadi M, Alavi Naeini A, Askari G, Khorvash F, Heidari Z. The efficacy of alpha-lipoic acid in improving oxidative, inflammatory, and mood status in women with episodic migraine in a randomised, double-blind, placebo-controlled clinical trial. Int J Clin Pract 2021;75(9):e14455.
Aslfalah H, Jamilian M, Ansarihadipour H, Abdollahi M, Khosrowbeygi A. Effect of alpha-lipoic acid supplementation on the lipid profile and lipid ratios in women with gestational diabetes mellitus: A clinical trial study. Int J Reprod Biomed 2020;18(12):1029-1038.
Sun F, Jiang D, Cai J. Effects of valsartan combined with a-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis. BMC Endocr Disord 2021;21(1):178.
Serhiyenko VA, Serhiyenko LM, Sehin VB, Serhiyenko AA. Effect of alpha-lipoic acid on arterial stiffness parameters in type 2 diabetes mellitus patients with cardiac autonomic neuropathy. Endocr Regul 2021;55(4):224-233.
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Turck D, et al. Scientific opinion on the relationship between intake of alpha-lipoic acid (thioctic acid) and the risk of insulin autoimmune syndrome. EFSA J 2021;19(6):e06577.
Vajdi M, Mahmoudi-Nezhad M, Farhangi MA. An updated systematic review and dose-response meta-analysis of the randomized controlled trials on the effects of Alpha-Lipoic acid supplementation on inflammatory biomarkers. Int J Vitam Nutr Res 2021.
Abdelrahman KA, Ibrahim AS, Osman AM, Aly MG, Ali AS, Farrag WS. Alpha lipoic acid with pulsed radiofrequency in treatment of chronic lumbosacral radicular pain: A prospective, randomized study. Medicine (Baltimore) 2021;100(24):e26344.
Desideri I, Lucidi S, Francolini G, et al. Use of an alfa-lipoic, methylsulfonylmethane, Boswellia serrata and bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833). Med Oncol 2022;39(8):113.
Habibi M, Abbasi B, Fakhari Zavareh Z, et al. Alpha-lipoic acid ameliorates sperm DNA damage and chromatin integrity in men with high DNA damage: a triple blind randomized clinical trial. Cell J 2022;24(10):603-11.
Christy J, Noorani S, Sy F, Al-Eryani K, Enciso R. Efficacy of alpha-lipoic acid in patients with burning mouth syndrome compared to that of placebo or other interventions: a systematic review with meta-analyses. J Dent Anesth Pain Med 2022;22(5):323-38.
Werida RH, Elshafiey RA, Ghoneim A, Elzawawy S, Mostafa TM. Role of alpha-lipoic acid in counteracting paclitaxel- and doxorubicin-induced toxicities: a randomized controlled trial in breast cancer patients. Support Care Cancer 2022;30(9):7281-92.
Divkovic A, Radic K, Sabitovic D, et al. Effect of alpha-lipoic acid supplementation on low-grade squamous intraepithelial lesions-double-blind, randomized, placebo-controlled trial. Healthcare (Basel) 2022;10(12):2434.
Mishra A, Reeta KH, Sarangi SC, Maiti R, Sood M. Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial. Psychopharmacology (Berl) 2022;239(11):3525-35.
De Lima DN Jr, Costa Filho CWL, Frota IJ, et al. a-Lipoic acid as adjunctive treatment for schizophrenia: a randomized double-blind study. J Clin Psychopharmacol 2023;43(1):39-45.
Iannuzzo F, Basile GA, Campolo D, et al. Metabolic and clinical effect of alpha-lipoic acid administration in schizophrenic subjects stabilized with atypical antipsychotics: A 12-week, open-label, uncontrolled study. Curr Res Pharmacol Drug Discov 2022;3:100116.
Jibril AT, Jayedi A, Shab-Bidar S. Efficacy and safety of oral alpha-lipoic acid supplementation for type 2 diabetes management: a systematic review and dose-response meta-analysis of randomized trials. Endocr Connect 2022;11(10):e220322.
Roszkowska AM, Spinella R, Oliverio GW, et al. Effects of the topical use of the natural antioxidant alpha-lipoic acid on the ocular surface of diabetic patients with dry eye symptoms. Front Biosci (Landmark Ed) 2022;27(7):202.
Bonetti M, Lauritano D, Ottaviani GM, et al. Oxygen-ozone therapy associated with alpha lipoic acid plus palmitoylethanolamide and myrrh versus ozone therapy in the combined treatment of sciatic pain due to herniated discs: observational study on 318 patients. Int J Environ Res Public Health 2022;19(9):5716.
Holotiuk IS, Kryzhanivska AY, Holotiuk SI, Holotiuk VV, Maliborska SV. EFFECTIVENESS OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE IN PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ASSESSED BY ELECTRONEUROMYOGRAPHY OF SUPERFICIAL PERONEAL AND SURAL NERVES. Exp Oncol 2022;44(4):300-306.
Libonati GA, Leone A, Martellucci S, et al. Prevention of Recurrent Benign Paroxysmal Positional Vertigo: The Role of Combined Supplementation with Vitamin D and Antioxidants. Audiol Res. 2022 Aug 22;12(4):445-456.
Basile GA, Iannuzzo F, Xerra F, et al. Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study. Int J Environ Res Public Health 2023;20(3):2358.
Altunina N, Bondarchuk O. EFFECTS OF ALPHA-LIPOIC ACID ON GLYCEMIC STATUS IN 2 TYPE DIABETES PATIENTS WITH ?HRONIC CORONARY SYNDROME. Wiad Lek 2022;75(12):3074-3079.
Su F, Xia Q. Effects of Valsartan and Amlodipine Tablets Combined with a-Lipoic Acid on T-AOC, IL-6 and ß2-MG Levels in Patients with Diabetic Nephropathy. Altern Ther Health Med 2023.
Ahmadi M, Keshavarz SA, Abbasi B. Effects of alpha lipoic acid supplementation on serum lipid profile in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. ARYA Atheroscler 2022;18(4):1-8.
Bonetti M, Lauritano D, Ottaviani GM, et al. New Approach to Chronic Back Pain Treatment: A Case Control Study. Biomedicines 2022;11(1):73.
Sanz-González SM, Raga-Cervera J, Aguirre Lipperheide M, et al. Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients. Arch Soc Esp Oftalmol (Engl Ed). 2020 Mar;95(3):120-129.
Halabi Z, El Helou C, Al Balushi H, et al. Alpha Lipoic Acid Toxicity: The First Reported Mortality in an Adult Patient After Multiorgan Failure. J Emerg Med 2023;64(2):190-194.
Banik S, Ghosh A, Sato H, Onoue S. The efficacy of alpha-lipoic acid in the management of burning mouth syndrome: An updated systematic review of randomized controlled clinical trials. Health Sci Rep 2023;6(4):e1186.
Gilron I, Robb S, Tu D, Holden RR, Milev R, Towheed T. Combination analgesic development for enhanced clinical efficacy (the CADENCE trial): a double-blind, controlled trial of an alpha-lipoic acid-pregabalin combination for fibromyalgia pain. Pain 2023.
Vg A, G S, C K, V A. A pilot study suggesting several benefits of alpha lipoic acid in patients with diabetes. Curr Vasc Pharmacol 2023.
Iuliano S, Greco F, Seminara G, et al. Positive effects of dietary supplementation with nutraceuticals on male subclinical hypogonadism: a pilot study. Minerva Endocrinol (Torino) 2023.
Corazza M, Arlotti E, Schettini N, Pacetti L, Bianchi A, Borghi A. Allergic contact dermatitis due to a-lipoic acid in a topical over-the-counter product: A case report. Contact Dermatitis 2023.
D'Orio M, De Vitis R, Taccardo G, et al. Clinical usefulness of nutraceutics with acetyl-L-carnitine, a-lipoic acid, phosphatidylserine, curcumin, C, E and B-group vitamins in patients awaiting for carpal tunnel release during COVID-19 pandemic: a randomized controlled open label prospective study. Acta Biomed 2023;94(S2):e2023050.
Hsieh RY, Huang IC, Chen C, Sung JY. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review. Nutrients 2023;15(16):3634.
Velasco-Amador JP, Prados-Carmona Á, Navarro-Triviño FJ. Contact urticaria syndrome caused by alpha-lipoic acid in a master formula for vulvar lichen sclerosus. Contact Dermatitis 2023;89(2):136-137.
Sacchetto L, Monzani D, Apa E, et al. The Effect of Alpha-Lipoic Acid in the Treatment of Chronic Subjective Tinnitus through the Tinnitus Handicap Inventory Scores. Audiol Res 2023;13(4):484-494.
Puliappadamb HM, Satpathy AK, Mishra BR, Maiti R, Jena M. Evaluation of Safety and Efficacy of Add-on Alpha-Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial. J Clin Pharmacol 2023.
Laky B, Bruckmann C, Blumenschein J, Durstberger G, Haririan H. Effect of a multi-nutrient supplement as an adjunct to nonsurgical treatment of periodontitis: A randomized placebo-controlled clinical trial. J Periodontol 2024; 95(2): 101-113.
Latini E, Bonasia G, Petroselli L, et al. Alpha-Lipoic Acid, Palmitoylethanolamide, Myrrh, and Oxygen-Ozone Therapy Improve Pharmacological Therapy in Acute Painful Lumbosacral Radiculopathy due to Herniated Disc. Pain Physician 2023;26(4):E363-E373.
Vajdi M, Noshadi N, Hassanizadeh S, Bonyadian A, Seyedhosseini-Ghaheh H, Askari G. The effects of alpha lipoic acid (ALA) supplementation on blood pressure in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. Front Cardiovasc Med 2023;10:1272837.
Figueiredo LP, Paim PVDSL, Cerqueira-Silva T, Barreto CC, Lessa MM. Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a double-blind randomized trial. Braz J Otorhinolaryngol 2023;90(1):101356.
Kishi T, Sakuma K, Miura G, et al. Alpha Lipoic Acid for Schizophrenia: A Systematic Review and Meta-analysis. J Clin Psychopharmacol 2023;43(5):477-478.
Orellana-Donoso M, López-Chaparro M, Barahona-Vásquez M, et al. Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis. Medicine (Baltimore) 2023;102(44):e35368.
Gülsah Ö, Bekir DE. Efficacy of intravenous alpha lipoic acid in the treatment of neuropathic pain due to carpal tunnel syndrome. Ideggyogy Sz 2023;76(9-10):319-326.
Abu-Zaid A, Baradwan S, Bukhari IA, et al. The effect of alpha-lipoic acid supplementation on anthropometric, glycemic, lipid, oxidative stress, and hormonal parameters in individuals with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. Obstet Gynecol Sci 2023.
Gilron I, Robb S, Tu D, et al. Randomized, double-blind, controlled trial of a combination of alpha-lipoic acid and pregabalin for neuropathic pain: the PAIN-CARE trial. Pain 2023.
Sehgal T, Ohri U, Mittal N, Attri P, Dishant F. A Case of Insulin Autoimmune Syndrome in an Indian Male Taking Alpha-Lipoic Acid. Cureus 2023;15(8):e43743.
Cantone E, D'Ascanio L, De Luca P, et al. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics. Eur Arch Otorhinolaryngol 2024.
Porcaro G, Laganà AS, Neri I, Aragona C. The Association of High-Molecular-Weight Hyaluronic Acid (HMWHA), Alpha Lipoic Acid (ALA), Magnesium, Vitamin B6, and Vitamin D Improves Subchorionic Hematoma Resorption in Women with Threatened Miscarriage: A Pilot Clinical Study. J Clin Med 2024;13(3):706.
Prado MB Jr, Adiao KJB. Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis. Can J Diabetes 2024;48(4):233-243.
Genazzani AD, Battipaglia C, Rusce L, et al. Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients. Gynecol Endocrinol 2024;40(1):2341701.
Ran GL, Li YP, Lu LC, Lan SH. Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials. J Diabetes Complications 2024;38(2):108691.
Baicus C, Purcarea A, von Elm E, Delcea C, Furtunescu FL. Alpha-lipoic acid for diabetic peripheral neuropathy. Cochrane Database Syst Rev 2024;1(1):CD012967.
Halabitska I, Oksenych V, Kamyshnyi O. Exploring the Efficacy of Alpha-Lipoic Acid in Comorbid Osteoarthritis and Type 2 Diabetes Mellitus. Nutrients 2024;16(19):3349.
Rezaei H, Ravankhah M, Ansari M, et al. Effects of Alpha-Lipoic Acid Supplementation on Weight Loss, Inflammatory, Lipid, and Hematological Levels in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Ren Nutr 2024.
Pingali U, Sravanasandya P, Mekala P, Yareeda S, Sireesha K, Khan I. A randomized, double-blind, placebo-controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin. J Postgrad Med 2024;70(4):191-197.
Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S. Effects of selected dietary supplements on migraine prophylaxis: A systematic review and dose-response meta-analysis of randomized controlled trials. Neurol Sci 2024.
Sooklert K, Thamakaison S, Nilyai S, Cherdchom S, Rojanathanes R, Sereemaspun A. The effects of alpha-lipoic acid transdermal patch for local subcutaneous fat reduction: A randomized, placebo-controlled, clinical trial in overweight volunteers. Contemp Clin Trials Commun 2024;42:101402.
Luo Y, Zhang J, Guo H. Alpha-lipoic acid on intermediate disease markers in overweight or obese adults: a systematic review and meta-analysis. BMJ Open 2025;15(4): e088363.
Pires IZ, Gobbo MODS, Sudo RYU, et al. Efficacy of Alpha Lipoic Acid Supplementation in Sperm Parameters: A Systematic Review and Meta-Analysis of Randomized Trials. Int Braz J Urol 2025;51(4):e20240614.
You Might Also Like
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.